Image Trademark with Serial Number 78263136
Status: 800 - Registered And Renewed
Image for trademark with serial number 78263136
Serial Number
78263136
Registration Number
2922700
Word Mark
Status
800 - Registered And Renewed
Status Date
2015-01-28
Filing Date
2003-06-17
Registration Number
2922700
Registration Date
2005-02-01
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s) Typeset
Design Searches
020131, 020133, 040703, 250305, 260302, 260314, 260321, 260502, 260525 - Stylized men, including men depicted in caricature form. Grotesque men formed by letters, numbers, punctuation or geometric shapes. Geometric figures or combinations of geometric figures representing a person. Backgrounds covered with dots (not mere stippling). Plain single line ovals. Three or more ovals. Ovals that are completely or partially shaded. Plain single line triangles. Triangles with one or more curved sides.
Published for Opposition Date
2004-11-09
Law Office Assigned Location Code
L30
Employee Name
STIGLITZ, SUSAN R
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Soft gelatin and non-animal film encapsulations and hard core enrobements of various pharmaceutical products, namely, [ AIDS related complex (ARC) therapeutic agents; ] antidiarrheals; antihistamines; analgesics; [ antacids; ] antiflatulents; [ antifungals; ] antiemetics; antipyretics; antiarthritics; [ antiinfectives for the treatment of fungal and viral infections; ] antinauseants; [ antiobesity; blood growth factor products; cancer therapy products; calcium supplements; cardiovascular agents, namely, calcium channel blockers for heart disease; ] cough and cold preparations; [ digestants; diuretics; dermatologicals for the treatment of skin disorders; ] gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; [ hormones; ] histamine H2 receptor antagonists; hypnotics; hypolipidemics; laxatives; musculoskeletal products, namely, [ calcium, ] vitamin D and osteoporosis treatments; psychotherapeutics; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of neurological disorders; drugs for the treatment of respiratory disorders; sedatives; drugs for the treatment of seizure disorders; sleep aids; [ drugs for the treatment of sexual dysfunction; ] transplant and immunosuppressant products, namely, cyclosporine; [ pharmaceutical preparations for the treatment of vascular disorders; ] soft gelatin and non-animal film encapsulations and hard core enrobements of natural medicine products, namely, [ a full line of ] herbal supplements; vitamin and mineral supplements and nutritional supplements, namely, [ a full line of ] vitamin and mineral supplements, nutritional supplements and herbal products; Pharmaceutical preparations, namely, [ AIDS related complex (ARC) therapeutic agents; ] antidiarrheals; antihistamines; analgesics; [ antacids; ] antiflatulents; [ antifungals; ] antiemetics; antipyretics; antiarthritics; [ antiinfectives for the treatment of fungal and viral infections; ] antinauseants; [ antiobesity; blood growth factor products; cancer therapy products; calcium supplements; cardiovascular agents, namely, calcium channel blockers for heart disease; ] cough and cold preparations; [ digestants; diuretics; dermatologicals for the treatment of skin disorders; ] gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; [ hormones; ] histamine H2 receptor antagonists; hypnotics; hypolipidemics; laxatives; musculoskeletal products, namely, [ calcium, ] vitamin D and osteoporosis treatments; psychotherapeutics; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of neurological disorders; drugs for the treatment of respiratory disorders; sedatives; drugs for the treatment of seizure disorders; sleep aids; [ drugs for the treatment of sexual dysfunction; ] transplant and immunosuppressant products, namely, cyclosporine; [ pharmaceutical preparations for the treatment of vascular disorders; ] soft gelatin and non-animal film encapsulations and hard core enrobements of natural medicine products, namely, [ a full line of ] herbal supplements; vitamin and mineral supplements and nutritional supplements, namely, [ a full line of ] vitamin and mineral supplements, nutritional supplements and herbal products
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2003-06-23
Primary Code
005
Current Trademark Owners
Party Type
32 - 2nd New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
32 - 2nd New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Maury M. Tepper, III
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2003-05-081032598BXTrue
Trademark Events
Event DateEvent Description
2003-11-25ASSIGNED TO EXAMINER
2003-11-25NON-FINAL ACTION E-MAILED
2004-05-26PAPER RECEIVED
2004-05-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2004-05-25CORRESPONDENCE RECEIVED IN LAW OFFICE
2004-06-25LETTER OF SUSPENSION E-MAILED
2004-08-04PAPER RECEIVED
2004-08-04CORRESPONDENCE RECEIVED IN LAW OFFICE
2004-08-12AMENDMENT FROM APPLICANT ENTERED
2004-08-24Sec. 1(B) CLAIM DELETED
2004-08-25EXAMINERS AMENDMENT E-MAILED
2004-08-25EXAMINER'S AMENDMENT ENTERED
2004-08-27APPROVED FOR PUB - PRINCIPAL REGISTER
2004-09-03ASSIGNED TO LIE
2004-09-09ASSIGNED TO LIE
2004-09-09LAW OFFICE PUBLICATION REVIEW COMPLETED
2004-09-15CASE FILE IN TICRS
2004-10-20NOTICE OF PUBLICATION
2004-11-09PUBLISHED FOR OPPOSITION
2005-02-01REGISTERED-PRINCIPAL REGISTER
2006-05-17AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2009-07-11TEAS CHANGE OF CORRESPONDENCE RECEIVED
2009-07-11TEAS CHANGE OF CORRESPONDENCE RECEIVED
2011-01-21TEAS SECTION 8 & 15 RECEIVED
2011-02-03CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2011-02-03REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
2011-07-06TEAS SECTION 7 REQUEST RECEIVED
2011-07-13CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2011-07-21CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2011-07-25REGISTERED - SEC. 7 REQUEST ABANDONED
2012-12-26ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2014-04-30ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2014-12-24AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2014-12-31TEAS CHANGE OF CORRESPONDENCE RECEIVED
2015-01-13TEAS SECTION 8 & 9 RECEIVED
2015-01-28CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2015-01-28REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2015-01-28REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
2015-01-28NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
2015-08-05ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY